Bionano Genomics, Inc.
BNGO
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kitsā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.60
Price+0.63%
$0.01
1Y
Price
Market Cap
$5.253m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-82.3%
EBITDA Margin-115.4%
Net Profit Margin-80.3%
Free Cash Flow MarginRevenue
$28.720m
-6.7%
1y CAGR+2.8%
3y CAGR+15.8%
5y CAGREarnings
-$38.587m
+65.6%
1y CAGR+14.0%
3y CAGR-10.3%
5y CAGREPS
-$15.52
+82.4%
1y CAGR+44.5%
3y CAGR+14.6%
5y CAGRBook Value
$49.799m
$79.062m
Assets$29.263m
Liabilities$7.370m
DebtDebt to Assets
9.3%
-0.3x
Debt to EBITDAFree Cash Flow
-$18.674m
+73.0%
1y CAGR+39.8%
3y CAGR+11.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company